Elevance Health (NYSE:ELV) EVP Ratnakar Lavu Sells 1,300 Shares of Stock

Elevance Health, Inc. (NYSE:ELV) EVP Ratnakar Lavu sold 1,300 shares of the firm’s stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $440.00, for a total value of $572,000.00. Following the sale, the executive vice president directly owned 14,849 shares in the company, valued at approximately $6,533,560. This represents a 8.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Elevance Health Trading Down 1.4%

ELV opened at $426.17 on Friday. The stock has a market capitalization of $92.08 billion, a PE ratio of 18.17, a P/E/G ratio of 1.97 and a beta of 0.63. Elevance Health, Inc. has a one year low of $274.84 and a one year high of $450.69. The business’s 50 day moving average price is $412.92 and its 200 day moving average price is $373.58. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.47 and a current ratio of 1.47.

Elevance Health (NYSE:ELV) last announced its quarterly earnings data on Wednesday, October 21st. The company reported $6.99 earnings per share for the quarter, topping the consensus estimate of $4.71 by $2.28. The company had revenue of $50.44 billion during the quarter, compared to analyst estimates of $49.28 billion. Elevance Health had a net margin of 2.55% and a return on equity of 14.97%. The firm’s revenue for the quarter was up .7% compared to the same quarter last year. During the same period last year, the business earned $6.03 EPS. As a group, equities research analysts expect that Elevance Health, Inc. will post 29.16 EPS for the current year.

Elevance Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, December 18th. Stockholders of record on Friday, December 4th will be paid a dividend of $1.72 per share. The ex-dividend date is Friday, December 4th. This represents a $6.88 annualized dividend and a dividend yield of 1.6%. Elevance Health’s dividend payout ratio is presently 29.34%.

Wall Street Analysts Forecast Growth

Several analysts have commented on ELV shares. The Goldman Sachs Group reiterated a “neutral” rating and issued a $451.00 price target on shares of Elevance Health in a research note on Friday, October 23rd. Leerink Partners lifted their price objective on shares of Elevance Health from $364.00 to $395.00 and gave the company a “market perform” rating in a report on Friday, July 17th. Sanford C. Bernstein set a $488.00 price target on shares of Elevance Health in a research note on Thursday, July 16th. Morgan Stanley boosted their target price on shares of Elevance Health from $404.00 to $449.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 22nd. Finally, Robert W. Baird lifted their price target on Elevance Health from $393.00 to $406.00 and gave the company a “neutral” rating in a research report on Thursday, October 22nd. Fifteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $456.48.

Elevance Health News Summary

Here are the key news stories impacting Elevance Health this week:

• Positive Sentiment: Zacks Research raised its FY2026 EPS estimate to $29.02 from $27.06, and lifted forecasts for Q1 2027 and Q1 2028 to $11.73 and $12.61, respectively. An additional analyst also raised its Q2 EPS estimate, though the report did not provide the revised figure. Q2 EPS Estimate for Elevance Health Lifted by Analyst
• Neutral Sentiment: EVP Ratnakar Lavu sold 1,300 shares for $572,000, an 8.05% reduction in his holdings. He still directly owned 14,849 shares after the transaction, making the sale a limited insider-sentiment signal. SEC insider transaction filing
• Neutral Sentiment: A separate article considers what would need to be true for Elevance to be an attractive stock purchase, but the supplied article information does not state its conclusion. What Needs To Be True To Buy Elevance Health Stock?
• Negative Sentiment: Zacks Research lowered estimates for Q4 2026 EPS to $2.00 from $2.43, Q3 2027 to $6.01 from $6.70, and Q3 2028 to $7.09 from $7.75. These cuts temper the positive revisions and point to a less favorable outlook for some future quarters.

Institutional Trading of Elevance Health

Several large investors have recently added to or reduced their stakes in the stock. Activest Wealth Management lifted its stake in shares of Elevance Health by 146.2% in the 3rd quarter. Activest Wealth Management now owns 64 shares of the company’s stock valued at $25,000 after purchasing an additional 38 shares during the last quarter. Kilter Group LLC acquired a new stake in shares of Elevance Health during the 2nd quarter worth about $28,000. WealthCollab LLC increased its stake in Elevance Health by 42.2% during the 1st quarter. WealthCollab LLC now owns 91 shares of the company’s stock worth $27,000 after buying an additional 27 shares during the period. Elevation Wealth Partners LLC raised its holdings in shares of Elevance Health by 600.0% during the second quarter. Elevation Wealth Partners LLC now owns 105 shares of the company’s stock valued at $41,000 after buying an additional 90 shares during the last quarter. Finally, Tacita Capital Inc acquired a new stake in Elevance Health during the 2nd quarter worth about $44,000. Institutional investors own 89.24% of the company’s stock.

About Elevance Health

Elevance Health, Inc is a U.S. health benefits and services company. Formerly known as Anthem, Inc, it adopted the Elevance Health name in 2022 while retaining the Anthem brand for many of its health plans.

The company offers medical, pharmacy, dental, vision and behavioral health coverage, including plans for individuals and employers as well as programs serving Medicare and Medicaid members. Its services also include care management, pharmacy benefit services and other health-related capabilities through its Carelon business.

Elevance Health operates primarily in the United States, with health plans serving members across multiple states and access to broader provider networks through its Blue Cross Blue Shield affiliations.